Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28129987

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2017 Mar 11
First author
Neoptolemos JP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Mar 11;389(10073):985-986. doi: 10.1016/S0140-6736(17)30126-5.
    note
    Source null
    related pmid
    28129986
    relationship
    Comment in
  2. citation
    Lancet. 2017 Apr 15;389(10078):1517-1518. doi: 10.1016/S0140-6736(17)30947-9.
    note
    Source null
    related pmid
    28422026
    relationship
    Comment in
  3. citation
    Chirurg. 2017 Jun;88(6):539. doi: 10.1007/s00104-017-0454-8.
    note
    Source null
    related pmid
    28573531
    relationship
    Comment in
  4. citation
    Lancet. 2017 Aug 26;390(10097):847-848. doi: 10.1016/S0140-6736(17)31806-8.
    note
    Source null
    related pmid
    28850041
    relationship
    Comment in
  5. citation
    Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1051-1058. doi: 10.1016/j.ijrobp.2017.05.040.
    note
    Source null
    related pmid
    29165271
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2019 Mar;20(3):336-337. doi: 10.1016/S1470-2045(19)30107-X.
    note
    Source null
    related pmid
    30842047
    relationship
    Comment in

Authors and identifiers

  1. name
    Neoptolemos JP
    type
    Author
  2. name
    Palmer DH
    type
    Author
  3. name
    Ghaneh P
    type
    Author
  4. name
    Psarelli EE
    type
    Author
  5. name
    Valle JW
    type
    Author
  6. name
    Halloran CM
    type
    Author
  7. name
    Faluyi O
    type
    Author
  8. name
    O'Reilly DA
    type
    Author
  9. name
    Cunningham D
    type
    Author
  10. name
    Wadsley J
    type
    Author
  11. name
    Darby S
    type
    Author
  12. name
    Meyer T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Neoptolemos JP
    type
    Author
  2. name
    Palmer DH
    type
    Author
  3. name
    Ghaneh P
    type
    Author
  4. name
    Psarelli EE
    type
    Author
  5. name
    Valle JW
    type
    Author
  6. name
    Halloran CM
    type
    Author
  7. name
    Faluyi O
    type
    Author
  8. name
    O'Reilly DA
    type
    Author
  9. name
    Cunningham D
    type
    Author
  10. name
    Wadsley J
    type
    Author
  11. name
    Darby S
    type
    Author
  12. name
    Meyer T
    type
    Author
bibliography ids
  1. nci-bib-337766f50cb9c750e8599ebb
book metadata
content sha256
b38d6cf88688b3dd32189342f321376549b23fdfcc6b9dda35a34e3c4f636e40
document type
citation
dois
  1. 10.1016/S0140-6736(16)32409-6
electronic publication date
display
2017 Jan 25
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28129987
immutable id
pubmed:28129987@b38d6cf88688b3dd32189342f321376549b23fdfcc6b9dda35a34e3c4f636e40
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10073
name
Lancet (London, England)
nlm unique id
2985213R
pages
1011-1024
volume
389
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Mar 11;389(10073):985-986. doi: 10.1016/S0140-6736(17)30126-5.
    note
    Source null
    related pmid
    28129986
    relationship
    Comment in
  2. citation
    Lancet. 2017 Apr 15;389(10078):1517-1518. doi: 10.1016/S0140-6736(17)30947-9.
    note
    Source null
    related pmid
    28422026
    relationship
    Comment in
  3. citation
    Chirurg. 2017 Jun;88(6):539. doi: 10.1007/s00104-017-0454-8.
    note
    Source null
    related pmid
    28573531
    relationship
    Comment in
  4. citation
    Lancet. 2017 Aug 26;390(10097):847-848. doi: 10.1016/S0140-6736(17)31806-8.
    note
    Source null
    related pmid
    28850041
    relationship
    Comment in
  5. citation
    Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1051-1058. doi: 10.1016/j.ijrobp.2017.05.040.
    note
    Source null
    related pmid
    29165271
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2019 Mar;20(3):336-337. doi: 10.1016/S1470-2045(19)30107-X.
    note
    Source null
    related pmid
    30842047
    relationship
    Comment in
outcomes validated
false
pmid
28129987
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
9c8541b9c92183f01cde6ae5d9c6c548b9b82a0bce1e410e680fc5c54ad67e7e
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Mar 11
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28129987/
title
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

Preserved source evidence · Not medical advice